NEWS AND EVENTS
COVID -19 Seroconversion Panels Now Available (14 x 1mL)
We are now offering COVID-19 Seroconversion Panels for purchase in our online store or through our sales representatives. These panels are used by diagnostic manufacturers and researchers during assay development, evaluation and troubleshooting COVID-19 test methods. This COVID-19 Seroconversion Panel contains 14 members with each member containing 1 vial of 1.0 mL of human plasma. Panel members collected in this longitudinal series are from a single donor during the progression of a SARS-CoV-2 infection. This panel shows the onset and decline of IgM, IgG and Ig total SARS-CoV-2 virus antibody titers over a period of 87 days. Panel members are undiluted, naturally occurring plasma samples collected in 4% sodium citrate. Units were aseptically filtered. No preservative has been added. All panel members are ready to use. SARS-CoV-2 antibody reactivity is measured for each panel member with LIAISON SARS-CoV-2 S1/S2 IgG assay-DiaSorin, Inc., SARS-CoV-2 IgG ELISA Test Kit and SARS-CoV-2 IgM ELISA Test Kit by Gold Standard Diagnostics, and VITROS Anti-SARS-CoV-2 IgG test and VITROS Anti-SARS-CoV-2 Total test by Ortho-Clinical Diagnostics, Inc. Contact us for more information or to inform us of your specific needs.
Now Available: Access Biologicals COVID-19 (15 x 1mL) Member Panel
Access Biologicals is actively collecting convalescent serum from patients that have been diagnosed with COVID-19using the Roche swab assay. Inclusion and exclusion criteria as well as donor data provided is listed below. CONFIRMED positive COVID-19 Donors≥10 and ≤30 days after positive test result The 15 member panel contains 1mL of convalescent serum from 15 unique donors and is shipped frozen on dry ice. If you have any questions regarding the panel or, other capabilities we have to provide you COVID-19 serum please contact us at: email@example.com or click here: Contact Us
GigaGen Enters COVID-19 Field
In a collaboration with Access Biologicals, GigaGen is now recruiting donors who have convalesced from COVID-19. GigaGen will begin developing a recombinant polyclonal antibody therapy for the treatment of COVID-19. The therapy known as rCIG (recombinant anti-coronavirus 19 hyperimmune gammaglobulin) is far more scalable than plasma-based methods and capable of creating a drug that can treat millions. Read the full story here
Gamma Irradiated Human Male AB Serum
Access Biological’s Gamma Irradiated Human Male AB Serum (hABs) is the ideal choice when working in the cell therapy space. Our hABs is manufactured under a proprietary process using bovine or therapeutic human thrombin, following a cGMP process. Our gamma irradiation process is fully validated and has undergone a virus validation study proving that gamma irradiation kills live virus. The virus validation study evaluated the ability to eliminate Pseudorabies Virus (PRY), Porcine Parvovirus (PPV), Bovine Viral, Diarrhea Virus (BVDV), Human Immunodeficiency Virus Type 1 (HIV), and Encephalomyocarditis Virus (EMC). The validation study tested several ranges of irradiation showing acceptable doses per run and demonstrated viral clearance on all levels.
Standard Human Serum
Our standard human serum is a proprietary products that is commonly used as a replacement for OTC (off-the-clot) serum. It is used as a negative base matrix and can be manufactured to customer specifications and can be manufactured with out without sodium citrate. The material is available in large batch sizes which minimizes cost and testing time for our customers. It is also more readily available than OTC with normal source plasma donations >200,000L annually and provides a more consistent product overall.
2020 American Society of Gene & Cell Therapy Annual Meeting
Access Biologicals is exhibiting at the 2020 American Society of Gene & Cell Therapy Annual Meeting in Boston, MA on May 12th through the 15th! Over 5,000 investigators from regulatory, biotechnology and academic industries will gather to discuss cutting-edge scientific breakthroughs. The agenda features over 900 abstract presentations, 110 speakers, 9 industry sponsored symposia along with workshops, receptions, networking events and more. Stop by booth 1315 to meet our knowledgeable staff and learn about our cell culture and cell therapy product portfolios. If you’d like to arrange a meeting in advance, please email firstname.lastname@example.org. For more information and to register: ASGCT 23rd annual meeting
View Product Portfolio